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Abstract: Red algae of Laurencia continue to provide wide structural diversity and complexity of
halogenated C15 acetogenin medium-ring ethers. Here, we described the isolation of three new C15
acetogenins (3–5), and one truncated derivative (6) from Laurencia viridis collected on the Canary
Islands. These compounds are interesting variations on the pinnatifidenyne structure that included
the first examples of ethynyl oxirane derivatives (3–4). The structures were elucidated by extensive
study of NMR (Nuclear Magnetic Resonance) data, J-based configuration analysis and DFT (Density
Functional Theory) calculations. Their antiproliferative activity against six human solid tumor cell
lines was evaluated.
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1. Introduction
Medium-ring haloethers of Laurencia, a significant subset of biologically active marine
natural products [1,2], continue to challenge innovative efforts as attractive targets for the
synthesis of stereochemically rich medium-sized oxacyclic compounds [3,4] or to explore biogenetic
hypothesis [5,6].
Z-Pinnatifidenyne and E-pinnatifidenyne (1–2) are representative and were reported in 1982
after isolation from the red algae Laurencia pinnatifida collected at Canary Islands [7]. Their structures
were established by espectroscopic methods, X-ray diffraction analysis and chemical correlations,
although, in 1991, the absolute configurations were reassigned based on a later X-ray analysis [8].
Recent synthetic approaches and biosynthetic studies of these eight-membered compounds have been
reported [9,10].
As part of our continuing interest on the chemistry of the genus Laurencia [11–14] and during the
course of our anticancer drug discovery program, we report the isolation of three new C15 acetogenins
and one truncated derivative from Laurencia viridis (Figure 1). The structures were elucidated based on
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detailed analysis of 1D and 2D NMR data and revealed that these compounds are variations on the
pinnatifidenyne structure with biogenetic relevance. In addition, a detailed study of NMR chemical
shifts by DFT calculations analysis was also undertaken and their antiproliferative activity against
human cancer cell lines A549 (lung), HBL-100 (breast), HeLa (cervix), SW1573 (lung), T-47D (breast)
and WiDr (colon) was evaluated.
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(3R,4S)-Epoxy-pinnatifidenyne (3) was isolated with yellow amorphous solid appearance. A 
molecular formula of C15H20BrClO2 was deduced by the presence of three pseudomolecular [M + 
Na]+ peaks in the HR-ESI-MS (High Resolution Electro Spray Ionization Mass Spectroscopy) 
spectrum at m/z 369.0227, 371.0216 and 373.0201 (ratio: 76:100:24, calcd. 369.0233, 371.0203, 371.0212 
and 373.0183). 
The 1H NMR spectrum revealed the presence of signals for two olefinic protons (δH 5.93 and 
5.72), six deshielded methines (δH 4.12, 3.97, 3.95, 3.65, 3.52 and 3.25), one acetylenic proton (δH 2.39), 
four methylenes (ranging from δH 1.64 to 2.96) and a terminal methyl group (δH 1.08) (Table 1). 
According to the molecular formula, the 13C NMR data (Table 2) along with the analysis of the 
edited HSQC (Heteronuclear Single Quantum Correlation) spectrum confirmed the presence of two 
olefinic carbons (δC 131.0 and 128.9), six heteroatom-bearing methynes (δC 83.1, 77.5, 65.8, 61.1, 55.3 
and 45.6), four methylenes (δC 34.5, 34.3, 30.0 and 27.1) and one methyl (δC 12.8). Careful examination 
of the homonuclear and heteronuclear NMR correlations exhibited in the COSY (Correlation 
SpectroscopY) and HSQC spectra allowed to observe a single 1H-1H spin system, C-3C-15, 
containing a double bond between C-9 and C-10 together with heteroatoms located on carbons C-3, 
C-4, C-6, C-7, C-12 and C-13. Moreover, HMBC (Heteronuclear Multiple Bond Correlation) 
cross-peaks from H-6 (δH 4.12) to C-12 (δC 83.1) established an ether linkage between C-6 and C-12, 
thus indicating the presence of a 3,4,7,8-tetrahydro-2H-oxocin heterocycle. The presence of a 
terminal epoxy alkyne was evident by the characteristic 1H and 13C signals (δH/δC, 3.25, ddd, J = 3.8, 
4.0, 8.4 Hz/55.3 (CH-4), 3.52, dd, J = 1.7, 4.0 Hz/45.6 (CH-3), 78.6 (C-2), and 2.39, d, J = 1.7 Hz/74.5 
(CH-1)) and by IR (Infrared) absorption at 3023 (it is the strongest signal) and 2134 cm−1. 
  
1
9
15
4
O
Br
Cl
H
H12
6
O
Br
Cl
H
H
O
3
O
Br
Cl
H
H
O
H
H
O
Br
Cl
H
H H
O
Figure 1. Structures of pinnatifidenynes and new metabolites.
2. Results and Discussion
(3R,4S)-Epoxy-pinnatifidenyne (3) was isolated with yellow amorphous solid appearance.
A molecular formula of C15H20BrClO2 was deduced by the presence of three pseudomolecular
[M + Na]+ peaks in the HR-ESI-MS (High Resolution Electro Spray Ionization Mass Spectroscopy)
spectrum at m/z 369.0227, 371.0216 and 373.0201 (ratio: 76:100:24, calcd. 369.0233, 371.0203, 371.0212
and 373.0183).
The 1H NMR spectrum revealed the presence of signals for two olefinic protons (δH 5.93 and 5.72),
six deshielded methines (δH 4.12, 3.97, 3.95, 3.65, 3.52 and 3.25), one acetylenic proton (δH 2.39), four
methylenes (ranging from δH 1.64 to 2.96) and a terminal methyl group (δH 1.08) (Table 1).
According to the molecular formula, the 13C NMR data (Table 2) along with the analysis of the
edited HSQC (Heteronuclear Single Quantum Correlation) spectrum confirmed the presence of two
olefinic carbons (δC 131.0 and 128.9), six heteroatom-bearing methynes (δC 83.1, 77.5, 65.8, 61.1, 55.3 and
45.6), four methylenes (δC 34.5, 34.3, 30.0 and 27.1) and one methyl (δC 12.8). Careful examination of the
homonuclear and heteronuclear NMR correlations exhibited in the COSY (Correlation SpectroscopY)
and HSQC spectra allowed to observe a single 1H-1H spin system, C-3→C-15, containing a double
bond between C-9 and C-10 together with heteroatoms located on carbons C-3, C-4, C-6, C-7, C-12 and
C-13. Moreover, HMBC (Heteronuclear Multiple Bond Correlation) cross-peaks from H-6 (δH 4.12) to
C-12 (δC 83.1) established an ether linkage between C-6 and C-12, thus indicating the presence of a
3,4,7,8-tetrahydro-2H-oxocin heterocycle. The presence of a terminal epoxy alkyne was evident by the
characteristic 1H and 13C signals (δH/δC, 3.25, ddd, J = 3.8, 4.0, 8.4 Hz/55.3 (CH-4), 3.52, dd, J = 1.7,
4.0 Hz/45.6 (CH-3), 78.6 (C-2), and 2.39, d, J = 1.7 Hz/74.5 (CH-1)) and by IR (Infrared) absorption at
3023 (it is the strongest signal) and 2134 cm−1.
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Table 1. 1H NMR data for compounds 3 and 4 (600 MHz, CDCl3).
Position
(3R,4S)-Epoxy-Pinnatifidenyne (3) (3S,4R)-Epoxy-Pinnatifidenyne (4)
δH (J in Hz) δH (J in Hz)
1 2.39, d (1.7) 2.38, d (1.7)
3 3.52, dd (1.7, 4.0) 3.44, dd (1.7, 4.0)
4 3.25, ddd (3.8, 4.0, 8.4) 3.12, ddd (4.0, 4.7, 7.6)
5 1.64, ddd (3.3, 8.4, 14.6)2.35, ddd (3.8, 9.7, 14.6)
2.06, ddd (4.7, 7.0, 14.5)
2.14, ddd (7.6, 7.6, 14.5)
6 4.12, ddd (2.5, 3.3, 9.7) 4.03, ddd (2.6, 4.7, 7.6)
7 3.95, ddd (2.5, 5.0, 11.6) 4.08, ddd (2.6, 5.1,11.7)
8 2,55, ddd (5.0, 6.6, 11.8)2.96, ddd (1.7, 11.6, 11.8)
2.56, ddd (5.8, 6.1, 12.5)
2.99, dddd (1.8, 11.6, 12.5)
9 5.72, dddd (1.7, 6.6, 10.1) 5.72, ddd (1.8, 6.1, 10.3)
10 5.93, br.dd (8.4, 10.1) 5.93, br.dd (8.5, 10.3)
11 2.44, ddd (1.3, 8.4, 14.0)2.61, br.dd (3.7, 14.0)
2.37, ddd (1.0, 8.5, 13.9)
2.62, br.dd (3.8, 13.9)
12 3.65, ddd (1.3, 3.7, 10.0) 3.53, ddd (1.0, 3.8, 10.1)
13 3.97, ddd (3.0, 3.3, 10.0) 3.97, ddd (2.8, 3.5, 10.1)
14 1.79, ddq (3.3, 7.2, 14.5)2.06, ddq (3.0, 7.2, 14.5)
1.80, ddq (2.8, 7.2, 14.5)
2.04, ddq (3.5, 7.2, 14.5)
15 1.08, t (7.2) 1.08, t (7.2)
Table 2. 13C NMR data for compounds 3–6 (150 MHz, CDCl3).
Position
3 4 5 6
Multi. δC δC δC δC
1 CH 74.5 74.3 83.1
2 C 78.6 78.6 80.5
3 CH 45.6 44.7 111.7
4 CH 55.3 54.8 140.2 200.2
5 CH2 34.3 33.7 35.1 49.1
6 CH 77.5 78.1 81.5 74.2
7 CH 65.8 64.8 60.3 65.4
8 CH2 34.5 34.4 34.5 34.4
9 CH 128.9 128.9 52.6 128.7
10 CH 131.0 131.0 52.9 131.3
11 CH2 30.0 30.4 32.1 31.2
12 CH 83.1 83.5 81.8 83.3
13 CH 61.1 61.2 59.9 61.8
14 CH2 27.1 27.3 26.8 27.7
15 CH3 12.8 12.9 12.9 12.8
The relative configuration of 3 was determined by a combination of NOESY (Nuclear Overhauser
Spectroscopy) data and J-based configuration approach. 1D-NOE (Nuclear Overhauser Effect)
correlations observed between H-6 and H-7/H-12 located all these protons on the same face of the
heterocycle (Figure 2), consistent with the orientation previously observed in the pinnatifidenynes.
The relationship between the configurations of C-12 and C-13 was established comparing chemical shifts
and coupling constants of 3 with those of pinnatifidenynes sharing the same C-15–C-6 fragment [7].
To complete the structural determination, the relative configuration of the epoxide as well as its
stereochemical relationship with C-6, the homo- and heteronuclear J couplings were measured [15,16].
The nJC,H values were accurately obtained using HSQC-HECADE (Heteronuclear Couplings from
ASSCI (American Standard Code for Information Interchange)-Domain experiments with E.COSY-type
cross peaks) experiment. The value of the coupling constants observed for 3JH3-H4 = 4.0 Hz, confirmed
by the observation of a strong dipolar correlation between H-3 and H-4, ensure the cis configuration for
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the epoxide (Figure 2c). Finally, the relative configurations at C-6 and C-4 can be conveniently started
from the large coupling constant displayed by the protons H-6 and H-5a (3JH6-H5a = 9.7 Hz) and the
observed value of 2JC6-H5b = −1.5 Hz that suggested an anti relationship for H-6 and H-5a (δH 2.35) and
a gauche orientation between H-6 and H-5b (δH 1.64), confirmed by the dipolar correlation between
H-5b and H-7. Similarly, it was established a threo-configuration between H-4 and H-5a explained by
the observed values of 3JH4-H5b = 8.4 Hz, 3JC3-H5a = 1.2 Hz and 2JC4-H5a = −2.2 Hz. Further support was
obtained from additional long-range heteronuclear coupling constants shown in Figure 3.
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compound 3 followed by the corresponding conformational searches, structure optimizations and 
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Figure 3. J-based configuration analysis for C-4/C-6 fragment of (3R,4S)-epoxy-pinnatifidenyne (3).
Compound 4 has the same molecular formula as 3 together with a close structural relationship.
Comparison of their 1H and 13C NMR chemical shifts and the analysis of their 2D NMR data
allowed us to establish an identical planar structure for both compounds (see Tables 1 and 2 and
Experimental Section).
The stereochemical relationships between the different stereogenic centres, including those of
epoxide, were performed using the above-described methods. The results of the NMR configurational
analysis are shown in Figure 4. The conclusion was that compounds 3 and 4 share the relative
configuration at centers C-6, C-7, C-12 and C-13, as well as the cis configuration of the epoxide, while
the oxirane rings present an opposite relative configuration.
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Figure 4. Configuration analysis for (3S,4R)-epoxy-pinnatifidenyne (4).
Although a J-bas d confi i n l analysis on 3 and 4 was don to determine its relative
configuration, a complementary computational study was undertaken. Chemical shift calculations
of carbon atoms attached to halogens are not accurate or difficult t calculate due to spin–orbit
c tributions. However, Kutateladze et al. [17] have recently reported the use of parametric corrections
to c lculate 13C chemical shifts by DFT using inexpensive computations at the B3LYP/6-31G(d) level for
structure ptimization and using theωB97xD/6-31G(d) level for the chemical s ift calculations. Using
this methodology, we built all possible stereoisomers for compound 3 followed by the corresponding
conformational searches, structure optimizations and chemical shift calculations for each calculated
conformer. As a result, it turned out that the 3R,4S,6S,7S,12S,13S isomer showed the lowest RMSD (Root
Mean Square Deviation) for compounds 3 and 4 (see Supplementary Materials, Table S1). This result
was coincident with our NMR-based propos l for the relative configuration of all stereogenic centers
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within the oxirane ring. However, it was clear that it was unable to solve the uncertainty within the
oxirane ring. Taking into account that the previously mentioned methodology uses only 13C data, we
decided to use chemical shift calculations of 1H for a second comparison as it has been shown that the
combination of both chemical shifts yields better results [12,13,18–20]. Thus, models of the two possible
diastereoisomers, 3S,4R,6S,7S,12S,13S (3a) and 3R,4S,6S,7S,12S,13S (3b), were built and conformational
searches on each one, consisting on 5000 steps of a hybrid MCMM (Monte Carlo Multiple Minimum),
Low-Mode sampling using the MMFF94 (Merck Molecular Force Field) force field, were completed.
Redundant conformers within a 12 kJ/mol energy window of the global minimum found were
eliminated using an RMSD cutoff of 1.0 Å. Next, all the resulting structures (seven conformers for
3a and five conformers for 3b) were geometrically optimized using DFT calculations [21] at the
B3LYP/6-31G** level of theory with the LACVP basis set in gas phase [22]. NMR shielding constants
(σ) were calculated according to the calculated relative Boltzmann populations for each conformer.
Finally, NMR chemical shifts were obtained scaling the calculated values by linear regression analysis
of experimental and computed data. In this analysis, the carbon nucleus with the attached bromine
atom and the acetylenic proton were not included due to their high deviations. Correlation coefficients
were almost identical for both stereoisomers (0.9885 for 3a vs. 0.9881 for 3b) using the 13C NMR data
but clearly better for isomer 3b using 1H-NMR data (0.9867 vs. 0.9696) (Figure 5 and Supplementary
Materials, Table S2). Calculation of the DP4 parameter [23] showed that the 3R,4S,6S,7S,12S,13S
diastereoisomer (3b) is the most likely solution, with a probability 99.9% using both 13C and 1H
data, therefore supporting our NMR-based proposal. Moreover, the same procedure was applied
to fit the data of compound 4 to the calculated values for diasteroisomers 3a and 3b (Figure 6 and
Supplementary Materials, Table S2). In this case, it turned out that the experimental data of 4 fitted
better with calculated data for the 3S,4R,6S,7S,12S,13S diasteroisomer (3a), confirming that compounds
3 and 4 are the two-possible cis oxirane stereoisomers.
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Figure 5. 1H and 13C correlations between calculated isotropic shieldings for the two simulated
diastereoisomers of (3,4)-epoxy-pinnatifidenyne and experimentally observed chemical shifts for
compound 3. Fitting parameters are indicated.
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Figure 6. 1H and 13C correlations between calculated isotropic shieldings for the two simulated
diastereoisomers of (3,4)-epoxy-pinnatifidenyne and experimentally observed chemical shifts for
compound 4. Fitting parameters are indicated.
Compound 5 was isolated as an amorphous solid that was determined to have the molecular
formula C15H20BrClO2 by HR-ESI-MS analysis. The presence in 5 of a terminal acetylene group
conjugated with a double bond was evident from UV (Ultra Violet) [λmax (log ε) 225 (3.59) nm] and
IR [νmax 3289 and 2300 cm−1] spectra. The 1H NMR experiment showed the characteristic shift
signals at δH 3.17 (1H, br.s), 5.63 (1H, br.d, J = 10.8 Hz) and 6.05 (1H, ddd, J = 7.6, 7.7, 10.8 Hz) of the
Z-enyne unit clearly related to Z-pinnatifidenyne (1). An extensive assessment of 1D and 2D NMR data
(Tables 2 and 3) compared to reported data for 1 [7] indicated that compound 5 differs to 1 containing
an extra disubstituted epoxide situated at C-9–C-10. The relative configuration of 5 was determined by
observation of dipolar correlations. Accordingly, the observed NOE enhancements from H-10 to H-9
and H-12, and from H-6 to H-7 and H-12 located all these protons on the same face of the molecule
(Supplementary Materials, Figure S23). The above data and the coupling constant for 3JH9-H10 = 4.0 Hz
provide evidence of the cis-orientation. This structure corresponds to a previously reported synthetic
epoxide obtained by epoxidation of 1 and published by our group in 1982 [7]. However, the data
published at that time and those obtained for our natural product did not correlate well. Therefore,
to confirm the structure of 5 as (9R,10S)-epoxy-Z-pinnatifidenyne, we decided to repeat the selective
epoxidation of 1. A product identical to 5 in all respects was obtained (see Experimental part).
Pinnatifidehyde 6 is a yellow amorphous solid that shows the molecular formula C12H18BrClO2,
evidenced by the presence of three pseudomolecular [M + Na]+ ions in the HR-ESI-MS spectrum at
m/z 331.0086, 333.0056 and 335.0033 (ratio 74:100:36, calcd. 331.0076, 333.0047, 335.0026).
1H and 13C NMR spectra (Tables 2 and 3) were reminiscent of the corresponding partial spectral
signals of pinnatifidenynes 1–2 or compounds 3–4. All those compounds share identical oxacyclic
and bromopropyl terminal chain (C-6→C-15 moiety), whereas the only notable differences were fixed
going towards C-4 were the structure appears truncated. Thus, the deshielded signals of a methylene
at δH 3.10 (br.dd, J = 8.0, 18.7 Hz) and 2.71 (dd, J = 4.0, 18.7 Hz), as well as the methine at δH 4.46 (ddd,
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J = 2.9, 4.0, 8.0 Hz), equivalent respectively to H2-5 and H-6 in pinnatifidenynes, showed correlations
in the HMBC with a carbonyl signal at δC 200.2 corresponding to one aldehyde group. The structure
of compound 6 possesses a truncated C12 carbon skeleton that may be derived from compounds 1
or 2 based on a probable oxidative process. Finally, analysis of the ROESY experiment confirmed
the relative configuration of all stereogenic centers presented in the molecule as equivalent to those
observed in the pinnatifidenynes (1, 2). Pinnatifidehyde 6 has been a synthetic intermediate target in
the total synthesis of compounds 1 and 2 [10,24]. The spectroscopic data of synthesized intermediate
by the Snyder group [10] was in agreement with the spectroscopic data of the natural product 6.
Table 3. 1H NMR data for compounds 5 and 6 (600 MHz, CDCl3).
Position
(9R,10S)-Epoxy-Z-Pinnatifidenyne (5) Pinnatifidehyde (6)
δH (J in Hz) δH (J in Hz)
1 3.17, br.s
3 5.63, br.d (10.8)
4 6.05, ddd (7.6, 7.7, 10.8) 9.80, br.s
5 2.58, dd (5.5, 7.7, 14.2)2.87, ddd (7.6, 7.6, 14.2)
2.71, dd (4.0, 18.7)
3.10, br.dd (8.0, 18.7)
6 3.79, ddd (2.3, 5.5, 7.6) 4.46, ddd (2.9, 4.0, 8.0)
7 4.11, ddd (2.3, 4.8, 11.7) 4.00, ddd (2.9, 5.1, 11.8)
8 1.94, ddd (11.6, 11.7, 13.2)2.67, ddd (3.5, 4.8, 13.2)
2.53, ddd (2.2, 5.1, 12.0)
2.96, ddd (5.1, 6.6, 12.0)
9 2.88, ddd (3.5, 4.0, 11.6) 5.72, ddd (2.2, 6.6, 10.3)
10 3.05, ddd (4.0, 4.6, 9.4) 5.96, br.dd, (8.3, 10.3)
11 1.65, ddd (9.4, 10.9, 14.0)2.58, ddd (3.3, 4.6, 14.0)
2.31, ddd, (1.4, 8.3, 14.0)
2.64, br.dd, (3.9, 14.0)
12 3.66, dd (3.3; 10.9) 3.67, ddd (1.4, 3.9, 10.3)
13 4.00, ddd (3.1, 3.1, 10.9) 3.84, ddd (2.8, 2.9, 10.3)
14 1.73, ddq (3.1, 7.3, 14.5)2.02, ddq (3.1, 7.3, 14.5)
1.74, ddq (2.9, 7.3, 14.6)
1.90, ddq (2.8, 7.3, 14.6)
15 1.08, t (7.3) 1.04, t (7.3)
As far as we know, pinnatifidehyde (6) is the third example of C12 acetogenins; the other two,
okamuragenin (7) and desepilaurallene (8) (Figure 7), have been isolated from Laurencia okamurai [25,26].
It has to be noted that the new compounds with the ethynyl oxirane unit (3 and 4) could be considered
biogenetic precursors of pinnatifidehyde.
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Figure 7. Structures of C12 metabolites isolated from Laurencia okamurai, okamuragenin (7) and
desepilaurallene (8).
The antiproliferative activity against six representative human solid tumor cell lines was evaluated
for compounds 3–6 [27]. The results showed that compound 5 was the most potent compound of the
series, with a modest activity against four of the cell lines tested (GI50 13–48 µM). Compound 4 was
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active against two of the cell lines (GI50 33–45 µM), whilst the remaining compounds were inactive
(GI50 > 50 µM) (see Supplementary Materials, Table S15).
3. Materials and Methods
3.1. General Experimental Procedures
Optical rotations were measured at room temperature in CHCl3 on a PelkinElmer-241 polarimeter
(Waltham, MA, USA) by using a sodium lamp. IR spectra were recorded on a Bruker IFS55
spectrophotometer (Ettlingen, Germany) using methanolic solutions over NaCl disk. NMR spectra
were recorded on a Bruker Avance 600 instrument (Karlsruhe, Germany) equipped with a 5-mm TCI
(Triple Resonance CryoProbe) inverse detection cryo-probe. 1H and 13C NMR chemical shifts were
referenced either to the CDCl3 or C6D6 solvent peaks at 300 K (CDCl3: δH 7.26, δC 77.0). COSY, HSQC,
HMBC and ROESY experiments were performed using standard pulse sequences. 3JH,H values were
measured from 1D 1H NMR. The HSQC-HECADE pulse sequence was used to measure long-range
heteronuclear coupling constants. All experiments were performed in the phase-sensitive mode
(States-TPPI (Time-Proportional Phase-Incrementation frequency discrimination) or echo-antiecho for
quadrature detection in F1) and used gradient coherence selection. The HSQC-HECADE experiment
was recorded using DIPSI (Decoupling in the Presence of Scalar Interactions) during the 40 ms of the
isotropic mixing period using a bandwidth of 10 kHz, and a J-scale factor of 1 was used. Prior to
Fourier transformation, zero filling was performed to expand the data to at least double the number of
acquired data points. HR-ESI-MS data were obtained on a LCT Premier XE Micromass spectrometer
(Waters, Milford, CT, USA). HPLC (High performance liquid chromatography) separations were
carried out with a LKB 2248 system (Bromma, Sweden) equipped with a photodiode array detector.
TLC (Thin layer chromatography) (Merck, Darmstadt, Germany) was visualized by spraying with
phosphomolybdic acid reagent (10% in EtOH) and heating.
3.2. Computational Methods
Conformational searches were undertaken using the Macromodel software (version 8.5,
Schrödinger Inc., San Diego, CA, USA) and the MMFF94 force field. Solvation effects of CHCl3 were
simulated using the generalized Born/surface area (GBSA) solvation model. Extended non-bonded
cutoff distances (a van der Waals cutoff of 8.0 Å and an electrostatic cutoff of 20.0 Å) were used. Local
minima within 10 kJ of the global minimum were saved and analysis of the results was undertaken
using Maestro software. Quantum mechanical calculations were carried out with the Jaguar package
(Jaguar; Schrödinger LLC, New York, NY, USA). Single-point energy calculations were performed at
the DFT theoretical level in the gas phase. The B3LYP hybrid functional with the LACVP ** basis set
was used. Chemical shifts were calculated using the gauge-including atomic orbital (GIAO) method.
Chemical shifts were calculated from their shielding constants that were first averaged according to
their relative Boltzmann populations using a Schrödinger Inc. python script. Proton chemical shifts for
each methyl group were averaged due to their conformational freedom.
3.3. Biological Material
Specimens of Laurencia viridis were collected by hand in the intertidal zone at Callao Salvaje,
Tenerife, Canary Islands, Spain (28◦07′12′ ′ N, 16◦46′45′ ′ W) in April 2013. A voucher specimen was
deposited at the Department of Biología Vegetal, Botánica, University of La Laguna, Tenerife (TFC
Phyc 7180, Herbarium Code of University of La Laguna).
3.4. Extraction and Isolation
Fresh specimens were extracted at room temperature using CHCl3: CH3OH (1:1, v/v). The resulting
extract (77.5 g) was separated in Silicagel 0.2–0.5 mm (Sigma-Aldrich, St. Louis, MO, USA) using a
gradient of n-hexane:ethyl acetate. The fraction corresponding at 10% of n-hexane was chromatographed
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in Sephadex LH-20 (Sigma, St. Louis, MO, USA) (n-hexane:CHCl3:CH3OH, 2:1:1). The first fraction
was treated in Sephadex LH-20 in the same conditions, yielding eight fractions. Selected fractions
that exhibits similar TLC profiles were rechromatographed on normal phase open column (Silicagel,
0.2–0.5 mm), using a gradient of n-hexane:acetone from 49:1 to 1:1, yielding compound 6 (3.2 mg) in the
second fraction. The compounds 3–5 were isolated and purified from the first fraction by HPLC using
µ-Porasil™ HPLC column (Waters, Milford, CT, USA), 10 µm, 19 × 150 mm, and n-hexane:ethyl acetate
(49:1) as mobile phase (Supplementary Materials, Scheme S1).
(3R,4S)-Epoxy-pinnatifidenyne (3): yellow, amorphous substance; [α]25D −17 (c 0.09, CHCl3); IR
νmax (CHCl3) 3023, 2788, 2379, 2134, 1748, 1698, 1647, 1571, 1500, 1401, 1311, 1189, 1098 cm−1; 1H
and 13C NMR data (CDCl3), see Tables 1 and 2; HR-ESI-MS m/z 369.0227, 371.0216 and 373.0201
[M + Na]+ (76:100:24) (calcd. for C15H20O235Cl79BrNa, 369.0233; C15H20O237Cl79BrNa, 371.0203;
C15H20O235Cl81BrNa, 371.0212; C15H20O237Cl81BrNa, 373.0183).
(3S,4R)-Epoxy-pinnatifidenyne (4): yellow, amorphous solid; [α]25D +30 (c 0.1, CHCl3); IR νmax
(CHCl3) 3289, 2935, 2117, 1743, 1454, 1384, 1103 cm−1; 1H and 13C NMR data (CDCl3), see
Tables 1 and 2; HR-ESI-MS m/z 369.0222, 371.0204 and 373.0195 [M + Na]+ (79:100:31) (calcd.
for C15H20O235Cl79BrNa, 369.0233; C15H20O237Cl79BrNa, 371.0203; C15H20O237Cl81BrNa, 371.0212;
C15H20O237Cl81BrNa, 373.0183).
(9R,10S)-Epoxy-Z-pinnatifidenyne (5): yellow, amorphous solid; [α]25D +8 (c 0.24, CHCl3); IR νmax
(CHCl3) 3289, 2935, 2300, 2015, 1743, 1454, 1379, 1103 cm−1; 1H and 13C NMR data (CDCl3),
see Tables 1 and 2; HR-ESI-MS m/z 369.0219, 371.0214 and 373.0197 [M + Na]+ (84:100:25) (calcd.
for C15H20O235Cl79BrNa, 369.0233; C15H20O237Cl79BrNa, 371.0203; C15H20O235Cl81BrNa, 371.0212;
C15H20O237Cl81BrNa, 373.0183).
Pinnatifidehyde (6): yellow, amorphous substance; [α]25D +33 (c 0.3, CHCl3); IR νmax (CHCl3) 3021,
2971, 2881, 2181, 2157, 2010, 1965, 1751, 1700, 1645, 1610, 1500, 1312, 1193, 1099 cm−1; 1H and 13C NMR
data (CDCl3), see Tables 1 and 2; HR-ESI-MS m/z 331.0086, 333.0056 and 335.0033 [M + Na]+ (74:100:36)
(calcd. for C12H18O235Cl79BrNa, 331.0076; C12H18O237Cl79BrNa, 333.0047; C12H18O235Cl81BrNa,
333.0047; C12H18O237Cl81BrNa, 335.0026).
3.5. Chemical Conversion of Z-Pinnatifidenyne (1) to (9R,10S)-Epoxy-Z-Pinnatifidenyne (5)
m-Chloroperbenzoic acid (26 mg) in dry benzene (1.2 mL) was added dropwise to a solution of
Z-pinnatifidenyne (23 mg) in benzene (0.84 mL) with stirring [7]. The reaction was led overnight and in
the final step calcium hydroxide was added to remove the excess of peracid. The solution was then
filtered and evaporated. The residue obtained was applied in to a silica gel (230–400 mesh, 60 Å) column
eluted whit ethyl acetate:n-hexane gradient (2:8 to 3:7) yielding (9R,10S)-epoxy-Z-pinnatifidenyne
(2.4 mg).
3.6. Antiproliferative Activity
Human solid tumor cell lines A549, HBL-100, HeLa, SW1573, T-47D and WiDr were a kind
gift from Prof. G. J. Peters (VU Medical Center, Amsterdam, The Netherlands). The cell lines were
cultured in RPMI 1640 medium (Flow Laboratories, Irvine, UK), supplemented with 5% fetal calf serum
(FCS, Gibco, Grand Island, NY, USA), 2 mM L-glutamine (Merck, Darmstadt, Germany), 100 U/mL
of penicillin G and 0.1 mg/mL of streptomycin (Sigma, St. Louis, MO, USA) at 37 ◦C in a 95%
humidified with 5% CO2 atmosphere. The in vitro antiproliferative activity was evaluated using the
sulforhodamine B (SRB, Sigma, St. Louis, MO, USA) assay with slight modifications [27]. Briefly, pure
compounds were initially dissolved in DMSO (Sigma, St. Louis, MO, USA) at 400 times the desired
final maximum test concentration. Cells were inoculated onto 96-well plates in a volume of 100 µL per
well at densities of 2500 (A549, HBL-100, HeLa and SW1573) or 5 000 (T-47D and WiDr) cells per well,
based on their doubling times. Control cells were exposed to an equivalent concentration of DMSO
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(0.25% v/v, negative control). Each agent was tested in triplicate at different dilutions in the range of
0.5–50 µM. The drug treatment was started on day 1 after plating. Drug incubation times comprised
48 h, after which time cells were precipitated with 25 µL ice-cold 50% (w/v) trichloroacetic acid (Merck,
Darmstadt, Germany) and fixed for 60 min at 4 ◦C. Then the SRB assay was performed. The optical
density (OD) of each well was measured at 530 nm, using BioTek’s PowerWave XS microplate reader.
Values were corrected for background OD from wells containing only medium. The percentage growth
(PG) was calculated in relation to untreated control cells (C) at each of the drug concentration levels
based on the difference in OD at the start (T0) and end of drug exposure (T), according to NCI formulas
Therefore, if T is greater than or equal to T0, the calculation is 100 × [(T − T0)/(C − T0)]. If T is
less than T0, denoting cell killing, the calculation is 100 × [(T − T0)/(T0)]. The effect is defined as
percentage of growth, where 50% growth inhibition (GI50) represents the concentration at which PG is
+50. With these calculations, a PG value of 0 represents no difference from the start of drug exposure,
while negative PG values denote net cell death.
Supplementary Materials: The following are available online at www.mdpi.com/1660-3397/16/1/5/s1.
Scheme S1: Isolation procedure for new acetogenins; Figures S1–S31: NMR and HRESIMS spectra of isolated
compounds; Figures S32 and S33: Correlations plots for 13C and 1H calculated vs. 13C and 1H experimental
data for compounds 3 and 4; Figure S34: DP4 app for (3R,4S)-epoxy-pinnatifidenyne 3; Table S1: Calculated
vs. experimental RMDS for compounds 3 and 4; Table S2: Scaled 13C and 1H chemical shifts for the two
studied diasteroisomers on B3LYP-D3 in gas phase; Tables S3–S14: Computational calculation results; Table S15:
Antiproliferative activity against human cancer cell lines.
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